Speech Outcomes After Palatal Lengthening Via Double Opposing Buccinator Myomucosal Flaps.

Autor:	Monte TM; From the Institute of Plastic and Craniofacial Surgery, SOBRAPAR Hospital, Campinas, Brazil., Raposo-Amaral CA; From the Institute of Plastic and Craniofacial Surgery, SOBRAPAR Hospital, Campinas, Brazil., Sabbag A, Gil A; From the Institute of Plastic and Craniofacial Surgery, SOBRAPAR Hospital, Campinas, Brazil., Menezes PT; From the Institute of Plastic and Craniofacial Surgery, SOBRAPAR Hospital, Campinas, Brazil., Raposo-Amaral CE
Jazyk:	angličtina
Zdroj:	Annals of plastic surgery [Ann Plast Surg] 2024 Apr 01; Vol. 92 (4), pp. 395-400.
DOI:	10.1097/SAP.0000000000003809
Abstrakt:	Background: Palatal lengthening is becoming a first-line treatment choice for cleft patients with velopharyngeal insufficiency (VPI). As cleft palate-related surgical outcomes are age dependent, speech outcomes may be similarly affected by patient age at the time of treatment. The primary goal of this study is to determine whether there are age-related speech outcome differences when double opposing buccinator myomucosal flaps are used as part of a palatal lengthening protocol and whether these outcome differences preclude utilization of this technique for specific patient age groups. Methods: A retrospective study was performed on consecutive nonsyndromic patients with VPI who underwent treatment using double opposing buccinator myomucosal flaps at our hospital between 2014 and 2021. Patients who completed the 15-month follow-up were stratified by age. Group A aged between 2 and 7 years (n = 14), group B aged 8 and 18 years (n = 23), and group C aged older than 18 years (n = 25) were included. Standardized perceptual speech evaluations and nasopharyngoscopy were performed. Hypernasality, soft palate mobility, and lateral palatal wall mobility were assessed both preoperatively and at a 15-month postoperative interval. Complications were also recorded. The χ2 test was used for statistical comparison. Results: All of the age-stratified patient groups in this study showed significant improvement in hypernasality, soft palate mobility, and lateral wall mobility (P < 0.01), with no statistically significant differences between the different patient age groups. Overall speech success was achieved in 69.4% of patients. Patients in group A achieved 78.6% speech success, patients in group B achieved 78.3% speech success, and patients in group C achieved 56% speech success, with no statistically significant differences being shown regarding speech success between the different patient age groups (P > 0.05). Conclusions: Regardless of age, palatal lengthening via double opposing buccinator myomucosal flaps similarly improves speech outcomes. Competing Interests: Conflicts of interest and sources of funding: none declared. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu